(Q37310808)

English

Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease.

scientific article published on January 2008

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18957923

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957923%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

review article

1 reference

stated in

Europe PubMed Central

title

Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18957923

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957923%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

main subject

inflammatory bowel diseases

0 references

author name string

Shamita B Shah

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18957923

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957923%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

Stephen B Hanauer

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18957923

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957923%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

publication date

1 January 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18957923

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957923%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

published in

Reviews in gastroenterological disorders

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18957923

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957923%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

volume

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18957923

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957923%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18957923

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957923%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

page(s)

159-168

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18957923

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957923%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

Identifiers

PubMed publication ID

18957923

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18957923

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957923%20AND%20SRC:MED&resulttype=core&format=json

(Q37310808)

Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)